RxSight (RXST) Net Cash Flow (2020 - 2026)
RxSight (RXST) posted Net Cash Flow of -$2.4 million for Q1 2026, up 75.39% on a QoQ basis from -$9.7 million in Q4 2025, and down 121.08% year-over-year from $11.3 million in Q1 2025.
RxSight (RXST) Net Cash Flow (2020 - 2026) Analysis & Trends
RxSight's Net Cash Flow history runs 7 years deep, the most recent figure standing at -$2.4 million for Q1 2026.
- Quarterly Net Cash Flow fell 121.08% year-over-year to -$2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$10.4 million (down 126.31% YoY) and the FY2025 annual result came in at $3.2 million, down 54.11% from the prior year.
- Net Cash Flow was -$2.4 million for Q1 2026 at RxSight, up from -$9.7 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $29.6 million in Q2 2022 and bottomed at -$29.9 million in Q1 2022.
- A 5-year average of -$402470.6 and a median of -$824000.0 in 2023 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2024 — Net Cash Flow jumped 2886.04% — and 2025, when it tumbled 26952.78%.
- RxSight's Net Cash Flow stood at $2.9 million in 2022, then sank by 106.05% to -$173000.0 in 2023, then jumped by 120.81% to $36000.0 in 2024, then tumbled by 26952.78% to -$9.7 million in 2025, then soared by 75.39% to -$2.4 million in 2026.
- Business Quant data shows RXST's Net Cash Flow at -$2.4 million in Q1 2026, -$9.7 million in Q4 2025, and -$10.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -1.70 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.11 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 768.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -503.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -500.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 202.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.19 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | RxSight | 221.81 Mn | -196.39 Mn | 23.50 Mn | -2.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.38 Mn |
| Mar 31, 2026 | -2.38 Mn |
| Dec 31, 2025 | -9.67 Mn |
| Dec 31, 2025 | -9.67 Mn |
| Sep 30, 2025 | -10.72 Mn |
| Sep 30, 2025 | -10.72 Mn |
| Jun 30, 2025 | 12.34 Mn |
| Jun 30, 2025 | 12.34 Mn |
| Mar 31, 2025 | 11.29 Mn |
| Mar 31, 2025 | 11.29 Mn |
| Dec 31, 2024 | 36,000.00 |
| Dec 31, 2024 | 36,000.00 |
| Sep 30, 2024 | -7.73 Mn |
| Sep 30, 2024 | -7.73 Mn |
| Jun 30, 2024 | -8.20 Mn |
| Jun 30, 2024 | -8.20 Mn |
| Mar 31, 2024 | 22.96 Mn |
| Mar 31, 2024 | 22.96 Mn |
| Dec 31, 2023 | -173,000.00 |
| Dec 31, 2023 | -173,000.00 |